Search clinical trials for: Sublingual film containing Igalmi

Total 30 results

Johns Hopkins University
National Institutes of Health (NIH)

Completed

Evaluating Peanut Immunotherapy Dissolving Film in Healthy Subjects

Pharmacokinetics | Peanut Allergy | Immunotherapy

United States
BioXcel Therapeutics Inc
Lotus Clinical Research, LLC

Completed

Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder

Schizophrenia | Bipolar Disorder | Schizo Affective Disorder | Agitation,Psychomotor | Schizophreniform Disorders

United States
Khon Kaen University

Not yet recruiting

The Effectiveness and Safety of Mucoadhesive Film Containing A.Oleracea Extract

Oral Mucosa

Thailand
BioXcel Therapeutics Inc
Cognitive Research Corporation

Completed

Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia (TRANQUILITY)

Dementia | Agitation,Psychomotor

United States
Orexo AB
Worldwide Clinical Trials

Completed

Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults (ISTART)

Opioid Dependence, on Agonist Therapy

United States
BioXcel Therapeutics Inc
Cognitive Research Corporation

Completed

Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder (SERENITY II)

Bipolar Disorder | Agitation,Psychomotor | Agitation Associated With Bipolar Disorder

United States
BioXcel Therapeutics Inc
Cognitive Research Corporation

Completed

Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

Schizophrenia | Agitation

United States
BioXcel Therapeutics Inc
Cognitive Research Corporation

Completed

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia (SERENITY I)

Schizophrenia | Schizoaffective Disorder | Agitation | Schizo Affective Disorder | Schizophreniform Disorders

United States
INSYS Therapeutics Inc

Completed

Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers

Opiate Dependence

United States
KU Leuven
Universitaire Ziekenhuizen KU Leuven; Research Foundation Flanders

Active, not recruiting

Longitudinal Identity Study of Childhood Cancer Survivors (LInC)

Pediatric Cancer

Belgium
Brown University
University of California, San Diego; Milton S. Hershey Medical Center; University... and other collaborators

Completed

PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation

Glioblastoma Multiforme

United States
Brigham and Women's Hospital

Not yet recruiting

Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Agitation | Schizophreniform Disorders
Indivior Inc.

Completed

Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population

Opioid Dependence

United States
NYU Langone Health

Not yet recruiting

Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia

Familial Dysautonomia

United States
Alar Pharmaceuticals Inc.

Completed

Single Ascending Dose Study of ALA-1000

Opioid-use Disorder

United States
William Ondo, MD
Sunovion

Not yet recruiting

Sublingual Apomorphine in Refractory Restless Legs Syndrome

Restless Legs Syndrome

United States
Sunovion

Completed

A Study to Examine APL-130277 in Patients With Parkinson's Disease

Parkinson's Disease

United States
Teva Pharmaceuticals USA

Withdrawn

An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA® in Opioid Dependent Subjects.

Evaluation of QTc Interval
Sumitomo Pharma America, Inc.

Completed

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Parkinson Disease

United States, Spain, United Kingdom, Italy, Canada, Austria, France, Germany
Sunovion

Completed

Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease

Parkinson Disease, Off Episodes

United States, Canada
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA); Baltimore City Health Department

Enrolling by invitation

Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine (OUTLAST-B)

Opioid-use Disorder

United States
Indivior Inc.

Completed

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

Opioid Dependence | Opioid Related Disorders

United States
Indivior Inc.

Completed

Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder

Opioid Use Disorder | Opioid-related Disorders

United States
Indivior Inc.

Completed

Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder

Healthy Volunteer | Opioid-use Disorder

United States
Indivior Inc.

Completed

Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder

Opioid Use Disorder

United States
Indivior Inc.

Completed

Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder

Opioid Use Disorder

United States
Jeff C. Huffman, MD
BioXcel Therapeutics Inc

Withdrawn

Dexmedetomidine Sublingual Film for the Management of Agitation in Delirium: Safety and Preliminary Efficacy

Delirium
University of California, Davis

Completed

Turmeric and Turmeric-containing Tablets and Sebum Production

Skin Inflammation

United States
New York State Psychiatric Institute

Withdrawn

Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder

Suicidal Ideation | Opioid-use Disorder

United States
GlaxoSmithKline

Terminated

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers

Diabetes Mellitus, Type 2

Australia

3

Subscribe